BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 29315361)

  • 1. Networks of tau distribution in Alzheimer's disease.
    Hoenig MC; Bischof GN; Seemiller J; Hammes J; Kukolja J; Onur ÖA; Jessen F; Fliessbach K; Neumaier B; Fink GR; van Eimeren T; Drzezga A
    Brain; 2018 Feb; 141(2):568-581. PubMed ID: 29315361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
    Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
    Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.
    Franzmeier N; Rubinski A; Neitzel J; Kim Y; Damm A; Na DL; Kim HJ; Lyoo CH; Cho H; Finsterwalder S; Duering M; Seo SW; Ewers M;
    Brain; 2019 Apr; 142(4):1093-1107. PubMed ID: 30770704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.
    Jones DT; Graff-Radford J; Lowe VJ; Wiste HJ; Gunter JL; Senjem ML; Botha H; Kantarci K; Boeve BF; Knopman DS; Petersen RC; Jack CR
    Cortex; 2017 Dec; 97():143-159. PubMed ID: 29102243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
    Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
    Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct influence of specific versus global connectivity on the different Alzheimer's disease biomarkers.
    Mutlu J; Landeau B; Gaubert M; de La Sayette V; Desgranges B; Chételat G
    Brain; 2017 Dec; 140(12):3317-3328. PubMed ID: 29194503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.
    Sintini I; Graff-Radford J; Jones DT; Botha H; Martin PR; Machulda MM; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Cereb Cortex; 2021 Feb; 31(3):1693-1706. PubMed ID: 33152765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer's disease.
    Myers N; Pasquini L; Göttler J; Grimmer T; Koch K; Ortner M; Neitzel J; Mühlau M; Förster S; Kurz A; Förstl H; Zimmer C; Wohlschläger AM; Riedl V; Drzezga A; Sorg C
    Brain; 2014 Jul; 137(Pt 7):2052-64. PubMed ID: 24771519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indication of retrograde tau spreading along Braak stages and functional connectivity pathways.
    Seemiller J; Bischof GN; Hoenig MC; Tahmasian M; van Eimeren T; Drzezga A;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2272-2282. PubMed ID: 33462630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity.
    Pereira JB; Ossenkoppele R; Palmqvist S; Strandberg TO; Smith R; Westman E; Hansson O
    Elife; 2019 Dec; 8():. PubMed ID: 31815669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.
    Chhatwal JP; Schultz AP; Johnson KA; Hedden T; Jaimes S; Benzinger TLS; Jack C; Ances BM; Ringman JM; Marcus DS; Ghetti B; Farlow MR; Danek A; Levin J; Yakushev I; Laske C; Koeppe RA; Galasko DR; Xiong C; Masters CL; Schofield PR; Kinnunen KM; Salloway S; Martins RN; McDade E; Cairns NJ; Buckles VD; Morris JC; Bateman R; Sperling RA;
    Brain; 2018 May; 141(5):1486-1500. PubMed ID: 29522171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
    Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
    Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
    Li X; Westman E; Thordardottir S; Ståhlbom AK; Almkvist O; Blennow K; Wahlund LO; Graff C
    J Alzheimers Dis; 2017; 56(1):327-334. PubMed ID: 27911308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau Accumulation and Network Breakdown in Alzheimer's Disease.
    Watanabe H; Bagarinao E; Yokoi T; Yamaguchi H; Ishigaki S; Mausuda M; Katsuno M; Sobue G
    Adv Exp Med Biol; 2019; 1184():231-240. PubMed ID: 32096042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks.
    Grothe MJ; Teipel SJ;
    Hum Brain Mapp; 2016 Jan; 37(1):35-53. PubMed ID: 26441321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.